Original Article Gene expression in thiazide diuretic or statin users in relation to incident type 2 diabetes

Thiazide diuretics and statins are used to improve cardiovascular outcomes, but may also cause type 2 diabetes (T2DM), although mechanisms are unknown. Gene expression studies may facilitate understanding of these associations. Participants from ongoing population-based studies were sampled for these longitudinal stud- ies of peripheral blood microarray gene expression, and followed to incident diabetes. All sampled subjects were statin or thiazide users. Those who developed diabetes during follow-up comprised cases (44 thiazide users; 19 statin users), and were matched to drug-using controls who did not develop diabetes on several factors. Supervised normalization, surrogate variable analyses removed technical bias and confounding. Differentially-expressed genes were those with a false discovery rate Q-value<0.05. Among thiazide users, diabetes cases had significantly differ - ent expression of CCL14 (down-regulated 6%, Q-value=0.0257), compared with controls. Among statin users, dia- betes cases had marginal but insignificantly different expression of ZNF532 (up-regulated 15%, Q-value=0.0584), CXORF21 (up-regulated 11%, Q-value=0.0584), and ZNHIT3 (up-regulated 19%, Q-value=0.0959), compared with controls. These genes comprise potential targets for future expression or mechanistic research on medication- related diabetes development.

[1]  P. Proost,et al.  In vivo regulation of chemokine activity by post‐translational modification , 2013, Immunology and cell biology.

[2]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[3]  J. Manson,et al.  Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. , 2012, Archives of internal medicine.

[4]  U. Stenius,et al.  Statins exhibit anticancer effects through modifications of the pAkt signaling pathway. , 2011, International journal of oncology.

[5]  M. Kostapanos,et al.  Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance , 2011, International journal of clinical practice.

[6]  Guang Chen,et al.  Evaluating surrogate variables for improving microarray multiple testing inference , 2011, Pharmaceutical statistics.

[7]  J. Pankow,et al.  Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. , 2010, Archives of internal medicine.

[8]  Jun Qin,et al.  A Data Set of Human Endogenous Protein Ubiquitination Sites* , 2010, Molecular & Cellular Proteomics.

[9]  L. Mascitelli,et al.  Statins and risk of incident diabetes , 2010, The Lancet.

[10]  F. Collins,et al.  Genomic medicine--an updated primer. , 2010, The New England journal of medicine.

[11]  John D. Storey,et al.  Supervised normalization of microarrays , 2010, Bioinform..

[12]  Yasuo Ohashi,et al.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.

[13]  E. Boerwinkle,et al.  Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications , 2010, Hypertension.

[14]  C. White,et al.  Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. , 2010, Diabetes research and clinical practice.

[15]  J. Sowers,et al.  Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity. , 2010, Hypertension.

[16]  R. Houtman,et al.  Nuclear Receptor-Coregulator Interaction Profiling Identifies TRIP3 as a Novel Peroxisome Proliferator-activated Receptor γ Cofactor* , 2009, Molecular & Cellular Proteomics.

[17]  D. Grobbee,et al.  Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diuretics. , 2009, American journal of hypertension.

[18]  T. Kimman,et al.  Genetic Susceptibility to Respiratory Syncytial Virus Bronchiolitis in Preterm Children Is Associated With Airway Remodeling Genes and Innate Immune Genes , 2009, The Pediatric infectious disease journal.

[19]  K. Reynolds,et al.  Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines , 2008, The Annals of pharmacotherapy.

[20]  A. Perl,et al.  CCL genes in multiple sclerosis and systemic lupus erythematosus , 2008, Journal of Neuroimmunology.

[21]  John D. Storey,et al.  Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis , 2007, PLoS genetics.

[22]  A. Owen,et al.  Incident diabetes in clinical trials of antihypertensive drugs , 2007, The Lancet.

[23]  W. Elliott,et al.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis , 2007, The Lancet.

[24]  H. Shimano,et al.  Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. , 2006, Journal of atherosclerosis and thrombosis.

[25]  B. Davis,et al.  Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2006, Archives of internal medicine.

[26]  C. Orengo,et al.  Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma , 2006, BMC Genomics.

[27]  G. Bakris,et al.  Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review , 2006, Hypertension.

[28]  M. Hamilton,et al.  Effect of antihypertensive agents on the development of type 2 diabetes mellitus. , 2006, Mayo Clinic proceedings.

[29]  K. Nakai,et al.  Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. , 2005, Genome research.

[30]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[31]  A. Laupacis,et al.  Antihypertensive therapy and incidence of type 2 diabetes: a systematic review. , 2004, Diabetes care.

[32]  Y. Matsuzawa,et al.  Thyroid Hormone Receptor Interacting Protein 3 (Trip3) Is a Novel Coactivator of Hepatocyte Nuclear Factor-4α , 2002 .

[33]  R. Brent,et al.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. , 1995, Molecular endocrinology.

[34]  K. Arakawa,et al.  Apolipoprotein AI mRNA levels in WHHL rabbits. , 1990, Atherosclerosis.